News | Radiation Therapy | April 01, 2016

Pyrexar Announces New Partnership to Bring Hyperthermia Cancer Therapy to Cuba

Distribution network will include Cuba, the West Indies, Panama and Venezuela

Pyrexar Medical, hyperthermia products, Cuba, West Indies, Clinitech Co. Ltd.

April 1, 2016 — Pyrexar Medical announced a new distribution partnership with Clinitech Co. Ltd., bringing Pyrexar’s hyperthermia technologies into Cuba, the West Indies, Panama and Venezuela.

Cancer deaths are high in Cuba at 138 per 100,000, according to World Life Expectancy.com, an organization that tracks death causality throughout the world. Cuba cancer stats rank 31 in the world, slightly lower than the United Kingdom, and several points higher than the United States. According to a study in 2001-2003 by the National Cancer Registry, lung, prostate, throat and colon cancers had high incidence in men, while breast, cervix, lung and colon cancers were the most prevalent in women.

Clinitech will be providing sales and service for the Pyrexar family of superficial, interstitial and deep regional hyperthermia devices. Leading their team is Ross University School of Medicine Oncology Professor Kamal Malaker, M.D., Ph.D., who has successfully used hyperthermia technology in the treatment of cancer. “We are excited to bring this relatively under-explored, under-utilized, well-proven, life-saving technology to the region.” said Wazir Mohammed, Clinitech’s president.

The distribution territory includes: Antigua, Aruba, Bahamas, Barbados, Belize, Bermuda, Bonaire, British Virgin Islands, Cayman Islands, Cuba, Curacao, Dominica, Dominican Republic, Grenada, Guyana, Haiti, Jamaica, Montserrat, Panama, Puerto Rico, Saba, St. Ecstasies, St Kitts & Nevis, St. Lucia, St. Maarten, St. Vincent. Suriname, Trinidad and Tobago, Turks and Caicos, U.S. Virgin Islands (St. Thomas, St. Croix and St John) and Venezuela.

For more information: www.pyrexar.com

Related Content

Stronger Distribution Networks to Bolster Radiotherapy Patient Positioning Accessories
News | Patient Positioning Radiation Therapy | July 19, 2019
A recent study projects global market revenues for radiotherapy patient positioning accessories will exceed revenues of...
CMS Proposes New Alternative Payment Model for Radiation Oncology
News | Radiation Oncology | July 17, 2019
The Centers for Medicare and Medicaid Services (CMS) issued a proposal for an advanced alternative payment model (APM)...
AAPM 2019 Features More Than 40 Presentations on ViewRay's MRIdian MRI-guided Radiotherapy
News | Image Guided Radiation Therapy (IGRT) | July 16, 2019
ViewRay Inc. announced that the company's MRIdian System is the focus of more than 40 abstracts selected by the...
RaySearch Releases Version 3A of RayCare Oncology Information System
Technology | Oncology Information Management Systems (OIMS) | July 15, 2019
RaySearch has released RayCare 3A, a new version of the next-generation oncology information system (OIS). RayCare is...
IBA Launches Monte Carlo Patient QA for Varian Halcyon at AAPM 2019
Technology | Quality Assurance (QA) | July 10, 2019
IBA announced the launch of the latest functionality of the SciMoCa Monte Carlo Patient QA solution at the 61st annual...
Researchers Use Artificial Intelligence to Deliver Personalized Radiation Therapy
News | Radiation Therapy | July 09, 2019
New Cleveland Clinic-led research shows that artificial intelligence (AI) can use medical scans and health records to...
The Beamscan 3-D water phantom with the Varian Halcyon radiotherapy system

The Beamscan 3-D water phantom with the Varian Halcyon radiotherapy system. Image courtesy of PTW.

News | Quality Assurance (QA) | July 08, 2019
At this year’s American Association of Physicists in Medicine (AAPM) show, July 14-18 in San Antonio, Texas, PTW will...